PLASMA-CONCENTRATION OF DISOPYRAMIDE GIVEN AS CAPSULES AND CONTROLLED RELEASE TABLETS

被引：6

作者：

ARNMAN, K

GRAFFNER, C

RIKNER, L

RYDEN, L

VOOG, L

机构：

[1] ASTRA LAKEMEDEL AB,RES LABS,S-15185 SODERTALJE,SWEDEN

[2] AB HASSLE,RES LABS,S-43120 MOLNDAL 1,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 24卷 / 02期

关键词：

D O I：

10.1007/BF00613817

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：199 / 203

页数：5

共 19 条

[1] THE EFFECT OF ENZYME-INDUCTION ON THE METABOLISM OF DISOPYRAMIDE IN MAN [J].

AITIO, ML ;

MANSURY, L ;

TALA, E ;

HAATAJA, M ;

AITIO, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) :279-285

[2] EFFECT OF INTRAVENOUS DISOPYRAMIDE PHOSPHATE ON RECURRENT PAROXYSMAL TACHYCARDIAS [J].

CAMM, J ;

WARD, D ;

SPURRELL, RAJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (05) :441-449

[3] PLASMA-BINDING OF DISOPYRAMIDE [J].

DAVID, BM ;

MADSEN, BW ;

ILETT, KF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (06) :614-618

[4] ANTIARRHYTHMIC EFFICACY OF INTRAVENOUS THERAPY WITH DISOPYRAMIDE PHOSPHATE [J].

DEANO, DA ;

WU, D ;

MAUTNER, RK ;

SHERMAN, RH ;

EHSANI, AE ;

ROSEN, KM .

CHEST, 1977, 71 (05) :597-606

[5] COMPARATIVE BIOAVAILABILITY OF DISOPYRAMIDE AFTER MULTIPLE DOSING WITH STANDARD CAPSULES AND CONTROLLED-RELEASE TABLETS [J].

FORSSELL, G ;

GRAFFNER, C ;

NORDLANDER, R ;

NYQUIST, O .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (03) :209-213

[6]

Gatley M S, 1968, J R Coll Gen Pract, V16, P39

[7]

GRAFFNER C, 1981, INT J CLIN PHARM TH, V19, P414

[8]

HARTEL G, 1974, CLIN PHARMACOL THER, V15, P551

[9] PATIENT NONCOMPLIANCE [J].

HUSSAR, DA .

JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1975, NS15 (04) :183-&

[10]

HUSSAR DA, 1975, J AM PHARM ASSOC, V15, P201

← 1 2 →